zepbound tirzepatide pregnancy safety Use During GLP-1 medications like Ozempic, Wegovy

Being overweight and obese contributes to numerous health conditions, including cardiovascular disease, diabetes, sleep and musculoskeletal disorders, stroke, hormonal issues, certain cancers and a decreased lifespan

A 1 mL TB syringe is marked in 0.01 mL increments

Tirzepatide induces weight loss in patients with type 2 diabetes regardless of baseline BMI: a post hoc analysis of SURPASS-1 through -5 studies (abstract)

Tirzepatide is a dual-action GLP-1/GIP agonist and has shown slightly greater average weight loss in head-to-head studies

What Results to Expect: Improved blood sugar levels: By increasing postprandial insulin release and inhibiting gluconeogenesis, Tirzepatide improves glycemic control